GRENEVIA S.A. ZY 0,01/ PLFAMUR00012 /
26/09/2024 21:43:44 | Chg. -0.0040 | Volume | Bid21:59:58 | Ask21:59:58 | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
0.4695EUR | -0.84% | - Turnover: - |
0.4565Bid Size: 10,455 | 0.5000Ask Size: 10,455 | 274 mill.EUR | - | - |
Newsfile Corp
01:46
ROSEN, LEADING TRIAL ATTORNEYS, Encourages Paragon 28, Inc. Investors to Inquire About Securities Cl...
Newsfile Corp
01:39
ROSEN, A LEADING LAW FIRM, Encourages XPEL, Inc. Investors to Secure Counsel Before Important Octobe...
Newsfile Corp
01:36
ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Stellantis N.V. Investors to Secure Counsel Before Im...
Newsfile Corp
01:35
ROSEN, NATIONAL TRIAL LAWYERS, Encourages Starbucks Corporation Investors to Secure Counsel Before I...
Newsfile Corp
01:16
ROSEN, LEADING TRIAL ATTORNEYS, Encourages Coinbase Global, Inc. Investors to Secure Counsel Before ...
Newsfile Corp
01:09
DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Bumble Inc.
Newsfile Corp
01:07
ROSEN, TOP RANKED INVESTOR COUNSEL, Encourages DexCom, Inc. Investors to Secure Counsel Before Impor...
Newsfile Corp
00:43
ROSEN, GLOBAL INVESTOR COUNSEL, Encourages PDD Holdings Inc. f/k/a Pinduoduo Inc. Investors to Secur...
Newsfile Corp
00:37
ABR FINAL DEADLINE: ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Arbor Realty Trust, Inc. Investors to...
Newsfile Corp
00:26
ROSEN, NATIONALLY REGARDED INVESTOR COUNSEL, Encourages Domino's Pizza, Inc. Investors to Secure Cou...
Newsfile Corp
00:26
ROSEN, NATIONALLY REGARDED INVESTOR COUNSEL, Encourages Winnebago Industries, Inc. Investors to Inqu...
Newsfile Corp
00:24
ROSEN, A LONGSTANDING LAW FIRM, Encourages GitLab Inc. Investors to Secure Counsel Before Important ...
Newsfile Corp
00:22
DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of XPEL
Newsfile Corp
00:22
DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Moderna
Newsfile Corp
00:14
SEC Charges Cassava Sciences, Two Former Executives for Misleading Claims About Alzheimer's Clinical...